Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses - Wikidata - awgldk - TriplyDB

Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses

Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses

http://www.wikidata.org/entity/Q36118373

about

Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240 Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques.Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection.Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.Errors in data interpretation from genetic variation of human analytes.Complex immune correlates of protection in HIV-1 vaccine efficacy trials.Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.Systems serology: profiling vaccine induced humoral immunity against HIV.Human immunodeficiency virus type-1 (HIV-1) evades antibody-dependent phagocytosis.HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.HIV-1 specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galcer Blocking and Phagocytosis.Immunogenicity of NYVAC prime-protein boost HIV-1 envelope vaccination and SHIV challenge of nonhuman primates.Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.Progress in HIV vaccine development Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies

P2860

Q33620546-4853BDB0-DCCA-48CF-BD78-4CD60BCBF383 Q33804531-ADB56814-8D3F-489A-9A1C-62C9821B93EE Q33865785-FD257F50-F76E-432F-8A9D-E8A85056A047 Q33867299-AB61C6AA-F3EA-4EA7-A196-940116C5267F Q37402557-68ED7EBE-2B96-4269-A1AB-4ABAA39A183E Q37469197-118A125E-92F7-4F46-BCF4-9C7204A3F521 Q37510242-973F3C70-34C4-4F21-99C0-2C6A4B3D3307 Q37512871-FDB87E98-789E-4E38-B605-21CBDCDD9CD9 Q38692190-AD6CD12D-7243-4BCC-9268-883A33AD4A5D Q39108779-43B2BA32-773D-4259-91A1-DB8349F4E8A1 Q39189458-320C37E2-96C5-46C9-8DFF-B28DC8CF1877 Q40114912-1D79FD31-E4BD-46F1-923C-8F546A72E81B Q44536209-132E96B9-2994-40AF-B906-095228818E11 Q47104983-6E8065A6-9EDF-447E-A434-9C4845AB7057 Q47215816-3B951460-0C98-4273-927B-C2ED7B1DF1B1 Q47547483-38FA64E4-39AF-44BC-B979-9EC71ED7685E Q47555844-4C1C0415-15C2-4A52-9FCA-389359F590E3 Q50043326-41406258-2644-4DEA-8766-A368D0A78920 Q52561260-79601781-611E-4314-B6A6-FB70B1818437 Q52590766-8571A252-FA48-4AD6-B38E-A1C3F4AF3F0F Q56970600-4559E58D-B4C1-45A0-B85B-4F5C2E5F0A7C Q58724429-86F57768-37B2-40D7-95DD-D79F8C34FD70

P2860

Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses

http://www.wikidata.org/entity/Q36118373

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Antibody-Mediated Internalizat ...... tibody Isotypes and Subclasses

@ast

Antibody-Mediated Internalizat ...... tibody Isotypes and Subclasses

@en

type

label

Antibody-Mediated Internalizat ...... tibody Isotypes and Subclasses

@ast

Antibody-Mediated Internalizat ...... tibody Isotypes and Subclasses

@en

prefLabel

Antibody-Mediated Internalizat ...... tibody Isotypes and Subclasses

@ast

Antibody-Mediated Internalizat ...... tibody Isotypes and Subclasses

@en

P1433

Q36118373-159727BE-B400-447E-A0D5-82DC12660E5D

P1476

Q36118373-9219550F-D587-4BB7-BBE5-5FA53A89283E

P2093

Q36118373-05420ED8-00B9-4E3A-84F5-7C1A584FB4A8

Q36118373-22C5D320-7680-4658-926E-D0EE363ED07E

Q36118373-30B8C49E-47A9-4344-9F23-00C34391C1B0

Q36118373-31ADAAB6-143C-49FE-B750-6CCE5731D2F1

Q36118373-3D26D000-8BD5-4006-A4D5-1E71AC09F958

Q36118373-3D8751DB-5422-45CD-9837-A38CF426C4A0

Q36118373-846257F4-AD31-411F-9777-CCE394C8C702

Q36118373-D1627B79-A416-4D1F-8273-5FC93C6E285B

Q36118373-E76E3B25-6AB8-4F6C-9802-C2F1E3C71DF6

Q36118373-F3830D22-5595-42E4-8E1E-34881AB1579A

P2860

Q36118373-01DB3350-788F-48D8-BF7E-B890A74F308B

Q36118373-041C3500-294E-47BA-B06C-3E5B71477AB6

Q36118373-078E8175-9026-4521-AC33-35B9F4328440

Q36118373-0C74AA2B-8D4B-44CB-B52F-DB3B4303BA58

Q36118373-1087DE78-7276-4280-A4DB-007703B025B9

Q36118373-10E8ED47-4A5C-4871-97E2-43CD2B387312

Q36118373-114BD25D-D82D-4880-847E-6C8A631AB048

Q36118373-18CBDE55-9D2F-4E53-967C-BD3BA7CCCA15

Q36118373-1B63305D-398E-4290-8192-351F368D8D48

Q36118373-1B7D8D06-6E19-40B8-BF3E-0AEED4F84803

P304

Q36118373-62E0DCDD-94EE-494F-8428-64B3C34FBC91

P31

Q36118373-C2B8E65B-B3DA-4773-8DF8-3E51E86B6800

P356

Q36118373-2784815C-FEC3-4998-A6EA-5F2BB7D00478

P433

Q36118373-FA0706A0-254A-4679-BAB1-9564BA806907

P478

Q36118373-C08D6E90-8370-4E02-9BB1-199083C200D1

P50

Q36118373-01E4F599-469E-4A9D-9CF6-11A8E887E513

Q36118373-4A3DF783-2D35-4883-9A88-6F85DBAA0803

Q36118373-4E323CC1-652E-4AAC-B127-1D1E4D282C56

Q36118373-5DF63F53-E313-4388-87E1-E64A3ED8C449

P577

Q36118373-6739D066-AB39-4146-8495-82A854921D3A

P698

Q36118373-55F4B62F-7674-4852-B217-BFA659825366

P921

Q36118373-8790143F-3530-45EF-8F20-F7F4D89F9A6C

P932

Q36118373-41CFDBA6-50C2-4C57-AEAB-37FB0A07DF3C

P356

JOURNAL.PPAT.1005817

P1433

P1476

Antibody-Mediated Internalizat ...... tibody Isotypes and Subclasses

@en

P2093

Agnès-Laurence Chenine

http://www.w3.org/2001/XMLSchema#string

Barton F Haynes

http://www.w3.org/2001/XMLSchema#string

Georgia D Tomaras

http://www.w3.org/2001/XMLSchema#string

Hua-Xin Liao

http://www.w3.org/2001/XMLSchema#string

Michael D McRaven

http://www.w3.org/2001/XMLSchema#string

Pinghuang Liu

http://www.w3.org/2001/XMLSchema#string

S Moses Dennison

http://www.w3.org/2001/XMLSchema#string

S Munir Alam

http://www.w3.org/2001/XMLSchema#string

Sheetal Sawant

http://www.w3.org/2001/XMLSchema#string

Thaddeus C Gurley

http://www.w3.org/2001/XMLSchema#string

P2860

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo

Immune correlates of vaccine protection against HIV-1 acquisition

The role of Fc-FcγR interactions in IgG-mediated microbial neutralization

Target shape dependence in a simple model of receptor-mediated endocytosis and phagocytosis

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques

Antibody Recognition of Cell Surface-Associated NS1 Triggers Fc- Receptor-Mediated Phagocytosis and Clearance of West Nile Virus-Infected Cells

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis

Effects of microparticle size and Fc density on macrophage phagocytosis

P304

e1005817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1005817

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

M Anthony Moody

Matthew Zirui Tay

LaTonya D Williams

P577

2016-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27579713

http://www.w3.org/2001/XMLSchema#string

P921

P932

5007037

http://www.w3.org/2001/XMLSchema#string